DrugsControl Media Services
DrugsControl.org

News Detail

SEC recommends Serum Institute’s hexavalent vaccine for marketing authorisation (22-06-2022)

New Delhi, 22 June 2022: The Subject Expert Committee (SEC) of the drug control organisation, which looks into the applications on vaccine approvals, has recommended grant of marketing authorisation permission of hexavalent vaccine of Serum Institute of India.

The comp......
View Details

Source : Pharmabiz

Related News